Eukles Asset Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-268
| Closed | -$4.72K | – | 227 |
|
|
2024
Q4 | $4.72K | Sell |
268
-20
| -7% | -$352 | ﹤0.01% | 179 |
|
|
2024
Q3 | $5.51K | Sell |
288
-35
| -11% | -$670 | ﹤0.01% | 175 |
|
|
2024
Q2 | $7.05K | Sell |
323
-39
| -11% | -$851 | ﹤0.01% | 164 |
|
|
2024
Q1 | $13.9K | Sell |
362
-782
| -68% | -$30K | 0.01% | 143 |
|
|
2023
Q4 | $76.9K | Sell |
1,144
-77
| -6% | -$5.18K | 0.04% | 103 |
|
|
2023
Q3 | $91.4K | Hold |
1,221
| – | – | 0.05% | 101 |
|
|
2023
Q2 | $113K | Hold |
1,221
| – | – | 0.06% | 98 |
|
|
2023
Q1 | $127K | Buy |
1,221
+8
| +0.7% | +$829 | 0.07% | 97 |
|
|
2022
Q4 | $140K | Hold |
1,213
| – | – | 0.08% | 97 |
|
|
2022
Q3 | $131K | Buy |
1,213
+79
| +7% | +$8.53K | 0.09% | 97 |
|
|
2022
Q2 | $205K | Buy |
1,134
+1
| +0.1% | +$181 | 0.13% | 91 |
|
|
2022
Q1 | $193K | Sell |
1,133
-39
| -3% | -$6.64K | 0.1% | 96 |
|
|
2021
Q4 | $245K | Sell |
1,172
-108
| -8% | -$22.6K | 0.12% | 94 |
|
|
2021
Q3 | $247K | Buy |
1,280
+211
| +20% | +$40.7K | 0.14% | 91 |
|
|
2021
Q2 | $303K | Buy |
+1,069
| New | +$303K | 0.17% | 85 |
|